The studies supported the roles of clinical pharmacists in providing intervention on
medication adherence in collaborative care models for patients with moderate to severe
depressions. To further evaluate whether a pharmacist intervention has superior over
other intervention teams in medication adherence, future collaborative care models may
be designed to treat the pharmacist-led intervention group as an intervention group and
other groups led by other healthcare providers as a control group. The results can then
provide an indication for future trends for a cost-effectiveness pharmacist intervention
program.